Skip to content
Menu

Satellos Bioscience Inc. MSCL.TO

Full chart Compare
Set alert

Price alert · MSCL.TO

All alert types
9.50 CAD -0.07 (-0.73%)

As ofNov 13, 2026, 3:59 PM EST

9.28 Day range 10.24
7.56 52-week range 18.98
YTD
+19.95%
1 year
+14.73%
Market cap
201.56M
EPS (ttm)
-2.70
Shares out
113.60M
Forward P/E
-4.05
YTD return
+19.95%
1-year return
+14.73%
Volume
6.49K
Avg volume
11.96K
Open
10.24
Previous close
9.57
Day's range
9.28 – 10.24
52-week range
7.56 – 18.98
Beta
1.03

 

No chart data for this range yet.

Key statistics

Enterprise value
65.97M
PEG ratio
0.00
Price / sales
0.00
Price / book
2.47
Dividend yield
0.00%
Payout ratio
0.00%
Revenue growth
0.00%
Free cash flow
-11.98M
Total cash
27.70M
Total debt
0
Return on equity
-58.84%
Short % of float
0.00%
50-day average
0.8074
200-day average
0.58125

About Satellos Bioscience Inc.

Satellos Bioscience Inc., a biotechnology company, develops regenerative therapeutics to treat degenerative muscle diseases primarily in Canada and Australia. The company uses its proprietary platform MyoReGenX, an automated microscopy system which recapitulates the muscle stem cell environment ex-vivo. Its lead program focuses on the discovery and development of a small molecule drug for the treatment of Duchenne. Satellos Bioscience Inc. was founded in 2018 and is headquartered in Toronto, Canada.

Sector
Healthcare
Industry
Biotechnology
Country
Canada
Website
satellos.com

News

No recent headlines

Headlines appear here as they are published.

Your note

Sign in to keep a note on MSCL.TO — it syncs with the Stock Master app.